Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease

Neurosurgical Review

Volumn 23, Issue 1, 2000, Pages 1-22

  Richard, Stéphane ^a   David, Philippe ^a   Marsot Dupuch, Kathlyn ^b   Giraud, Sophie ^c   Béroud, Christophe ^d   Resche, François ^e  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e CHU de Nantes   (France)

Author keywords

Angiogenesis; Endolymphatic sac tumor; Genetics; Hemangioblastoma; Von Hippel Lindau disease

Indexed keywords

DIFFERENTIAL DIAGNOSIS; ENDOLYMPHATIC SAC; FOLLOW UP; HEMANGIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0034098260     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101430050024     Document Type: Review

References (221)

1. Ahuja A, Gibbons KJ (1994) Endovascular therapy of central nervous system tumors. Neurosurg Clin N Am 5:541-554
2. Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, Stillman IE, Sukhatme VP (1999) Transforming growth factor beta 1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59:2210-2216
3. Atuk NO, Stolle C, Owen JA Jr, Carpenter JT, Vance ML (1998) Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multi-generational kindred. J Clin Endocrinol Metab 83:117-120
4. Bender BU, Altehofer C, Januszewicz A, Gartner R, Schmidt H, Hoffmann MM, Heidemann PH, Neumann HP (1997) Functioning thoracic paraganglioma: association with von Hippel-Lindau syndrome. J Clin Endocrinol Metab 82:3356-3360
5. Benjamin LE, Keshet E (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766
6. Béroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C (1998) Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256-258
7. Blamires TI, Friedman I, Moffat DA (1992) Von Hippel-Lindau disease associated with an invasive choroid plexus tumour presenting as a middle ear mass. J Laryngol Otol 106:429-435
8. Böhling T, Hatva E, Kujala M, Claesson-Welsh L, Alitalo K, Haltia M (1996) Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55:522-527
9. Boughey AM, Fletcher NA, Harding AE (1990) Central nervous system hemangioblastoma: a clinical and genetic study of 52 cases. J Neurol Neurosurg Psychiatr 53:644-648
10. Bradley JF, Collins DL, Schimke NR, Parrott HN, Rothberg P (1999) Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene. Am J Med Genet 87:163-167
11. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Höfler H, Latif F, Lerman M, Zbar B, Neumann HPH (1995) Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 95:551-556
12. Brauch H, Hoeppner W, Jahnig H, Wohl T, Engelhardt D, Speisberg F, Ritter MM (1997) Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the RET proto-oncogene. J Clin Endocrinol Metab 82:4101-4104
13. Brauch H, Weirich G, Hornauer MA, Storkel S, Wohl T, Bruning T (1999) Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 91:854-861
14. Bret P, Streichenberger N, Guyotat J (1999) Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel-Lindau disease: a case report. Br J Neurosurg 13:413-416
15. Brieger J, Weidt EJ, Schirmacher P, Storkel S, Huber C, Decker HJ (1999) Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth:an in vivo study on 29 tumors. J Mol Med 77:505-510
16. Brown DF, Gazdar AF, White CL III, Yashima K, Shay JW, Rushing EJ (1997) Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas. J Neuropathol Exp Neurol 56:1349-1355
17. Brown DF, Dababo MA, Hladik CL, Eagan KP, White CL III, Rushing EJ (1998) Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Mod Pathol 11:55-59
18. Cervoni L, Franco C, Celli P, Fortuna A (1995) Spinal tumors and subarachnoid hemorrhage: pathogenetic and diagnostic aspects in five cases. Neurosurg Rev 18:159-162
19. Chakraborti PR, Chakrabarti KB, Doughty D, Plowman PN (1997) Stereotactic multiple arc radiotherapy. IV-Haemangioblastoma. Br J Neurosurg 11:110-115
20. Chan CC, Vortmeyer AO, Chew EY, Green WR, Matteson DM, Shen DF, Linehan WM, Lubensky IA, Zhuang Z (1999) VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol 117:625-630
21. Chandler HC Jr, Friedman WA (1994) Radiosurgical treatment of a hemangioblastoma: case report. Neurosurgery 34:353-355
22. Chang JH, Spraul CW, Lynn ML, Drack A, Grossniklaus HE (1998) The two-stage mutation model in retinal hemangioblastoma. Ophthalmic Genet 19:123-130
23. Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JR Jr (1998) Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28-35
24. Chang SD, Murphy M, Geis P, Martin DP, Hancock SL, Doty JR, Adler JR Jr (1998) Clinical experience with image-guided robotic radiosurgery (the cyberknife) in the treatment of brain and spinal cord tumors. Neurol Med Chir (Tokyo) 38:780-783
25. Chauveau D, Duvie C, Chrétien Y, Paraf F, Droz D, Melki P, Hélénon O, Richard S, Grünfeld JP (1996) Renal involvement in von Hippel-Lindau disease. Kidney Int 50:944-951
26. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Ming HW, Schmidt L, Kalman T, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B (1995) Germline mutations in the von Hippel-Lindau tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66-75
27. Chen F, Slife L, Kishida T, Mulvihill J, Tisherman SE, Zbar B (1996). Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. J Med Genet 33:716-717
28. Cheng TY, Su CH, Shyr YM, Lui WY (1997) Management of pancreatic lesions in von Hippel-Lindau disease. World J Surg 21:307-312
29. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629-642
30. Choyke PL, Glenn GM, Wagner JP, Lubensky IA, Thakore K, Zbar B, Linehan WM, Walther MM (1997) Epididymal cystadenomas in von Hippel-Lindau disease. Urology 49:926-931
31. Clinical Research Group for VHL in Japan (1995) Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum Mol Genet 4:2233-2237
32. Cohen HT, Zhou M, Welsh AM, Zarghamee S, Scholz H, Mukhopadhyay D, Kishida T, Zbar B, Knebelmann B, Sukhatme VP (1999) An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem Biophys Res Commun 266:43-50
33. Corless CL, Kibel AS, Iliopoulos O, Kaelin WG Jr (1997) Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum Pathol 28:459-464
34. Cornford EM, Hyman S, Black KL, Cornford ME, Vinters HV, Pardridge WM (1995) High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. J Neuropathol Exp Neurol 54:842-851
35. Cristante L, Herrmann HD (1999). Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir (Wien) 14:333-340
36. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER (1994) Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308
37. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, Ponder BA, Maher ER (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial pheochromocytoma. J Med Genet 32:885-886
38. Cybulski C, Krzystolik K, Maher ER, Richard S, Kurzawski G, Gronwald J, Lubinski J (1999) Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Hum Genet 105:333-336
39. Decker HJH, Weidt EJ, Brieger J (1997) The von Hippel-Lindau tumor suppressor gene. Cancer Genet Cytogenet 93:74-83
40. Delisle MB, Uro E, Rouquette E, Yardeni E, Rumeau JL (1994) Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease. J Clin Pathol 47:959-961
41. Eby TL, Makek MS, Fisch U (1988) Adenomas of the temporal bone. Ann Otol Rhinol Laryngol 97:605-612
42. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872-1879
43. Emery E, Hurth M, Lacroix-Jousselin C, David P, Richard S (1994) Les hémangioblastomes intrarachidiens. A propos d'une série récente de 20 cas. Neurochirurgie 40:165-173
44. Eskridge JM, McAuliffe W, Harris B, Kim DK, Scott J, Winn HR (1996) Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol 17:525-531
45. Evans DG, Maher ER, Macleod R, Davies DR, Craufurd D (1997) Uptake of genetic testing for cancer predisposition. J Med Genet 34:746-748
46. Ferragut J, Caimari M, Rituerto B, Gomez-Rivas B, Herrera M, Alonso F (1999) Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report. J Pediatr Endocrinol Metab 12:579-582
47. Filling-Katz MR, Choyke PL, Oldfield E, Charnas L, Patronas NJ, Glenn GM, Gorin MB, Morgan JK, Linehan WM, Seizinger BR, Zbar B (1991) Central nervous system involvement in von Hippel-Lindau disease. Neurology 41:41-46
48. Folker RJ, Meyerhoff WL, Rushing EJ (1997) Aggressive papillary adenoma of the cerebellopontine angle: case report of an endolymphatic sac tumor. Am J Otolaryngol 18:135-139
49. Gaeta M, Blandino A, Minutoli F, Pandolfo I (1999) Sudden unilateral deafness with endolymphatic sac adenocarcinoma: MRI. Neuroradiology 41:799-801
50. Gaffey MJ, Mills SE, Boyd JC (1994) Agressive papillary tumor of middle ear temporal bone and adnexal papillary cystadenoma: manifestations of von Hippel-Lindau disease. Am J Surg Pathol 18:1254-1260
51. Gallou C, Joly D, Méjean A, Staroz F, Martin N, Tarlet G, Orfanelli MT, Bouvier R, Droz D, Chrétien Y, Maréchal JM, Richard S, Junien C, Béroud C (1999) Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat 13:464-475
52. Giannini C, Scheithauer BW, Hellbusch LC, Rasmussen AG, Fox MW, McCormick SR, Davis DH (1998) Peripheral nerve hemangioblastoma. Mod Pathol 11:999-1004
53. Glasker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HP (1999) The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 67:758-762
54. Glavac D, Neumann HP, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F Engelhardt D, Plate KH, Hofler H, Chen F, Zbar B, Brauch H (1996) Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 98: 271-280
55. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 93:10589-10594
56. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klausner RD, Linehan WM (1997) Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94:9102-9107
57. Gokden M, Roth KA, Carroll SL, Wick MR, Schmidt RE (1997) Clear cell neoplasms and pseudoneoplastic lesions of the central nervous system. Semin Diagn Pathol 14:253-269
58. Goldfarb DA (1998) Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. J Intern Med 243:563-567
59. Gorospe M, Egan JM, Zbar B, Lerman M, Geil L, Kuzmin I, Holbrook NJ (1999) Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells. Mol Cell Biol 19:1289-1300
60. Grimbert P, Chauveau D, Rémy S, Richard S, Grünfeld JP (1999) Pregnancy in von Hippel-Lindau disease. Am J Obstet Gynecol 180:110-111
61. Gross DJ, Reibstein I, Weiss L, Slavin S, Stein I, Neeman M, Abramovitch R, Benjamin LE (1999) The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice. Clin Cancer Res 5:3669-3675
62. Grossniklaus HE, Thomas JW, Vigneswaran N, Jarrett WH III (1992) Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology 99: 140-145
63. Hatva E, Böhling T, Jaaskelainen J, Persico MG, Haltia M, Alitalo K (1996) Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 148:763-775
64. Hayasaka K, Tanaka Y, Satoh T, Mutoh H (1999) Hepatic hemangioblastoma: an unusual presentation of von Hippel-Lindau disease. J Comput Assist Tomogr 23:565-566
65. Heffner DK (1989) Low grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathological study of 20 cases. Cancer 64:2292-2302.
66. Heffner DK (1996) Are papillary adenomas endolymphatic sac tumors? Ann Otol Rhinol Laryngol 105:251-252
67. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DR, Gnarra JR, Linehan WM, Baylin SB (1995) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal cell carcinoma. Proc Natl Acad Sci USA 91:9700-9704
68. Hes FJ, Slootweg PJ, van Vroonhoven TJ, Hene RJ, Feldberg MA, Zewald RA, Ploos van Amstel JK, Hoppener JW, Pearson PL, Lips CJ (1999) Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Invest 29:68-75
69. Hes FJ, Feldberg MA (1999) Von Hippel-Lindau disease: strategies in early detection (renal, adrenal, pancreatic masses). Eur Radiol 9:598-610
70. Ho VT, Rao VM, Doan HT, Mikaelian DO (1996) Low grade adenocarcinoma of probable endolymphatic sac origin: CT and MR appearance. AJNR Am J Neuroradiol 17:168-170
71. Horton JA, Eelkema E, Albright AL (1989) Preoperative embolization of a hemangioblastoma. AJNR Am J Neuroradiol 10:203.
72. Hough DM, Stephens DH, Johnson CD, Binkovitz LA (1994) Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. AJR 162:1091-1094.
73. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1:822-826
74. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599
75. Irving RM (1998) The molecular pathology of tumours of the ear and temporal bone. J Laryngol Otol 112:1011-1018
76. Isaka T, Horibe K, Nakatani S, Maruno M, Yoshimine T (1999) Hemangioblastoma of the third ventricle. Neurosurg Rev 22:140-144
77. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI (1998) Downregulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95:12596-12601
78. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A (1999) Identification of the von Hippel-Lindau tumor suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96:12436-12441
79. Jamjoom A, Kane N, Nicoll J (1992) Metastasis of a renal carcinoma to a cerebellar haemangioblastoma in a case of von Hippel-Lindau disease. Neurosurg Rev 15:231-234
80. Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G, Neumann HPH (1998) Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 160:330-334
81. Kaelin WG Jr, Maher ER (1998) The VHL tumour suppressor gene paradigm. Trends Genet 14:423-426
82. Kaelin WG Jr (1999) Cancer. Many vessels, faulty gene. Nature 399:203-204
83. Kaelin WG Jr (1999) Choosing anticancer drug targets in the postgenomic area. J Clin Invest 104:1503-1506
84. Kamura T, Conrad MN, Yan Q, Conaway RC, Conaway JW (1999) The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cu12. Genes Dev 13:2928-2933
85. Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin WG Jr, Elledge SJ, Conaway RC, Harper JW, Conaway JW (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284:657-661
86. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M ( 1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847
87. Karsdorp N, Elderson A, Wittebol-Post D, Hene RJ, Vos J, Feldberg MA, van Gils AP, Jansen-Schillhorn van Veen JM, Vroom TM, Hoppener JW, Lips CJM (1994) Von Hippel-Lindau disease: new strategies in early detection and treatment. Am J Med 97:158-168
88. Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T (1999) VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology 53:208-210
89. Kempermann G, Neumann HP, Scheremet R, Volk B, Mann W, Gilsbach J, Laszig R (1996) Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 61:318-320
90. Kempermann G, Neumann HP, Volk B (1998) Endolymphatic sac tumours. Histopathology 33:2-10
91. Kerr DJ, Scheithauer BW, Miller GM, Ebersold MJ, McPhee TJ (1995) Hemangioblastoma of the optic nerve: case report. Neurosurgery 36:573-581
92. Knebelmann B, Ananth S, Cohen HT, Sukhatme VP (1998) Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 58:226-231
93. Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, Stearman R, Vasselli JR, Stetler-Stevenson WG, Kaelin WG Jr, Linehan WM, Klausner RD, Gnarra JR, Van de Woude GF (1999) The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 19:5902-5912
94. Krieg M, Marti HH, Plate KH (1998) Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 92:3388-3393
95. Kroll SL, Paulding WR, Schnell PO, Barton MC, Conaway JW, Conaway RC, Czyzyk-Krzeska MF (1999) von Hippel-Lindau protein induces hypoxia-regulated arrest of tyrosine hydroxylase transcript elongation in pheochromocytoma cells. J Biol Chem 274:30109-30114
96. Kuroiwa T, Tanaka H, Ohta T, Tsutsumi A (1996) Preoperative embolization of highly vascular brain tumors: clinical and histopathological findings. Noshuyo Byori 13:27-36
97. Lach B, Gregor A, Rippstein P, Omulecka A (1999) Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol 23:299-310
98. Lamiell JM, Salazar FG, Hsia YE (1989) Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68:1-29
99. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean A, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault CA, Maher E.R, Linehan WM, Zbar B (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-132
100. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z (1998) Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504-508
101. Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD (1999) Transcription-dependent nuclear cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 19:1486-1497
102. Leung SY, Chan AS, Wong MP, Yuen ST, Fan YW, Chung LP (1998) Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis. Hum Pathol 29:1322-1324
103. Levy AP, Levy NS, Goldberg MA (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and ils modulation by the von Hippel-Lindau protein. J Biol Chem 271:25492-25497
104. Levy M, Richard S (2000) Opinion of patients with VHL disease towards presymptomatic genetic testing for their children and prenatal diagnosis. J Med Genet (in press)
105. Libutti SK, Choyke PL, Bartlett DL, Vargas H, Walther M, Lubensky I, Glenn G, Linehan WM, Alexander HR (1998) Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 124:1153-1159
106. Lindau A (1926) Studien über Kleinhirnzysten. Bau, Pathogenese, und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand S1:1-128
107. Linehan WM, Lerman MI, Zbar B (1995) Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. J Am Med Ass 273:564-570
108. Lips CJ (1998) Clinical management of the multiple endocrine neoplasia syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease. J Intern Med 243:589-594
109. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W (1999) The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 13:1822-1833
110. Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC. Conaway JW, Kaelin WG Jr (1998) Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cu12. Mol Cell Biol 18:732-741
111. Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE (1996) Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 75:231-238
112. Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJ, Blijham GH, Voest EE (1997) Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol 8:1015-1022
113. Los M, Zeamari S, Foekens JA, Martin FBG, Gebbink MF, Voest EE (1999) Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene. Cancer Res 59:4440-4445
114. Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z (1996) Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 149:2089-2094
115. Lubensky IA, Pack S, Ault D, Vortmeyer AO, Libutti SK, Choyke PL, Walther MM, Linehan WM, Zhuang Z (1998) Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 153:223-231
116. Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, Whitehouse R, Dodd C, Lavin M, Hartley N, Super M, Evans DG (1996) A genetic register for von Hippel-Lindau disease. J Med Genet 33:120-127
117. Maher ER, Yates JRW, Ferguson-Smith MA (1990) Statistical analysis of the two-stage mutation model in von Hippel-Lindau disease and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet 27:311-314
118. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77: 1151-1163
119. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT (1996) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33:328-332
120. Maher ER, Kaelin WG Jr (1997) von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391
121. Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, Lebovics R, Sledjeski K, Choyke PL, Zbar B, Linehan WM, Oldfield EH (1997) Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461-1466
122. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275
123. Megerian CA, McKenna MJ, Nuss RC, Maniglia AJ, Ojemann RG, Pilch BZ, Nadol JB (1995) Endolymphatic sac tumours' histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 105:801-808
124. Mukherji SK, Albernaz VS, Lo WW, Gaffey MJ, Megerian CA, Feghali JG, Brook A, Lewin JS, Lanzieri CF, Talbot JM, Meyer JR, Carmody RF, Weissman JL, Smirniotopoulos JG, Rao VM, Jinkins JR, Castillo M (1997) Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 202:801-808
125. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP (1997) The von Hippel-Lindau tumor suppressor gene product interacts with SpI to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17:5629-5639
126. Murgia A, Martella M, Vinanzi C, Polli R, Perilongo G, Opocher G (2000) Somatic mosaicism in von Hippel-Lindau disease. Hum Mutat 15:114
127. Neumann HPH, Eggert HR, Weigel K, Freidburg H, Wiestler OD, Schollmeyer P (1989) Hemangioblastoma of the central nervous system: a 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24-30
128. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P, Wiestler O (1992) Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898-901
129. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329:1531-1538
130. Neumann HPH, Eng C, Mulligan LM, Glavac D, Ponder B, Crossey P, Maher E, Brauch H. (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with mutiple endocrine neoplasia type II. JAMA 274:1149-1151
131. Neumann HP, Lips CJ, Hsia YE, Zbar B (1995) Von Hippel-Lindau syndrome. Brain Pathol 5:181-193
132. Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, Ferstl FJ, Herbst EW, Schwarzkopf G, Hes FJ, Lips CJ, Lamiell JM, Masek O, Riegler P, Mueller B, Glavac D, Brauch H (1998) Prevalence, morphology, and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248-1254
133. Niemelä M, Lim YJ, Söderman M, Jääskelainäinen J, Lindquist C (1996) Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591-596
134. Niemelä M, Lemeta S, Summanen P, Böhling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kaariainen H, Pukkala E, Jääskelainäinen J (1999) Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochir (Wien) 141:1147-1156
135. Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP (1996) Mutation of the von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 179:151-156
136. Ogasawara KK, Ogasawara EM, Hirata G (1995) Pregnancy complicated by von Hippel-Lindau disease. Obstet Gynecol 85:829-831
137. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, Iliopoulos O (1998) The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1:959-968
138. Ohh M, Kaelin WG Jr (1999) The von Hippel-Lindau tumour suppressor protein: new perspectives. Mol Med Today 5: 257-263
139. Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, Conaway RC, Conaway JW, Kaelin WG Jr (1999) Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest 104: 1583-1591
140. Okuda H, Hirai S, Takaki Y, Kamada M, Baba M, Sakai N, Kishida T, Kaneko S, Yao M, Ohno S, Shuin T (1999) Direct interaction of the beta domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes. Biochem Biophys Res Commun 263:491-497
141. Olschwang S, Boisson C, Richard S, Resche F, Thomas G (1995) DNA-based presymptomatic diagnosis for von Hippel-Lindau disease by linkage analysis. Eur J Hum Genet 3:108-115
142. Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G (1998) Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum Muta;t 12:424-430
143. Othmane IS, Shields C, Singh A, Shields J, Goldman W (1999) Postpartum cerebellar herniation in von Hippel-Lindau syndrome. Am J Ophthalmol 128:387-389
144. Ouallet JC, Marsot-Dupuch K, Van Effenterre R, Kujas M, Tubiana JM (1997) Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel-Lindau disease. Case report. J Neurosurg 87:445-449
145. Pack SD, Zbar B, Pak E, Ault DO, Humphrey JS, Pham T, Hurley K, Weil RJ, Park WS, Kuzmin I, Stolle C, Glenn G, Liotta LA, Lerman MI, Klausner RD, Linehan WM, Zhuang Z (1999) Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 59:5560-5564
146. Page KA, Wayson K, Steinberg GK, Adler JR Jr (1993) Stereotaxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases. Surg Neurol 40:424-428
147. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D (1998) Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem 273:26277-26280
148. Palmer JM, Coker NJ, Harper RL (1989) Papillary adenoma of the temporal bone in von Hippel-Lindau disease. Otolaryngol Head Neck Surg 100:64-68
149. Pan L, Wang EM, Wang BJ, Zhou LF, Zhang N, Cai PW, Da JZ (1998) Gamma knife radiosurgery for hemangioblastomas. Stereotact Funct Neurosurg 70 [Suppl 1]:179-186
150. Panchwagh J, Goel A, Shenoy A (1999) Bilateral endolymphatic sac papillary carcinoma. Br J Neurosurg 13:79-81
151. Patrice SJ, Sneed PK, Flickinger JC, Shrieve DC, Pollock BE, Alexander E III, Larson DA, Kondziolka DS, Gutin PH, Wara WM, McDermott MW, Lunsford LD, Loeffler JS (1996) Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys 35:493-499
152. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD (1997) The von Hippel-Lindau tumor suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94:2156-2161
153. Pause A, Lee S, Lonergan KM, Klausner RD (1998) The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci USA 95:993-998
154. Poe DS, Tarlov EC, Thomas CB, Kveton JF (1993) Aggressive papillary tumours of the temporal bone. Otolaryngol Head Neck Surg 108:80-86
155. Pollak A, Bohmen A, Spycher M, Fisch U (1995) Are papillary adenomas endolymphatic sac tumours? Ann Otol Rhinol Laryngol 94:613-619
156. Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER (1997) Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors. Am J Hum Genet 60 :765-771
157. Reifenberger G, Reifenberger J, Bilzer T, Wechsler W, Collins VP (1995) Coexpression of transforming growth factor-alpha and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. Am J Pathol 147:245-250
158. Reijneveld J, Hanlo P, Groenewoud G, Jansen G, van Overbeeke K, Tulleken C (1997) Endolymphatic sac tumor: a case report and review of the literature. Surg Neurol 48:368-373
159. Resche F, Moisan JP, Mantoura J, de Kersaint-Gilly A, Andre MJ, Perrin-Resche I, Menegalli-Boggelli D, Lajat Y, Richard S (1993) Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg 20:197-304
160. Resto VA, Lustig LR (2000) Hemangioblastoma of the internal acoustic canal in a patient with von Hippel-Lindau disease: a case report and review of
161. Richard S, Beigelman C, Gerber S, Van Effenterre R, Gaudric A, Sahel M, Binaghi M, De Kersaint-Gilly A, Houtteville JP, Brunon JP, Guérin J, Cornu P, Redondo A, Hurth M, Resche F (1994) L'hémangioblastome existe-t-il en dehors de la maladie de von Hippel-Lindau? Neurochirurgie 40:145-154
162. Richard S, Chauveau D, Chrétien Y, Beigelman C, Denys A, Fendler JP, Fromont G, Hélénon O, Nizard S, Paraf F, Proye C, Resche F, Plouin PF (1994) Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Adv Nephrol 23:1-27
163. Richard S, C Beigelman C, Duclos JM, Fendler JP, Plauchu H, Plouin PF, Resche F, Schlumberger M, Vermesse, Proye C (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 116:1076-1081
164. Richard S, Campello C, Taillandier L, Parker F, Resche F (1998) Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med 243:547-553
165. Richard S, Giraud S, Hammel P, Beroud C, Joly D, Olschwang S, Resche F (1998) La maladie de von Hippel-Lindau: une maladie à impact tissulaire multiple. Presse Med 27:1112-1120
166. Richards FM, Schofield PN, Fleming S, Maher ER (1996) Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet 5:639-644
167. Ritter MM, Frilling A, Crossey PA, Hoppner W, Maher ER, Mulligan L, Ponder BA, Engelhardt D (1996) Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab 81:1035-1037
168. Roche PH, Dufour H, Figarella-Branger D, Pellet W (1998) Endolymphatic sac tumors: report of three cases. Neurosurgery 42:927-932
169. Roessler K, Dietrich W, Haberler C, Goerzer H, Czech T (1999) Multiple spinal "miliary" hemangioblastomas in von Hippel-Lindau (VHL) disease without cerebellar involvement. A case report and review of the literature. Neurosurg Rev 22:130-134
170. Roncaroli F, Giangaspero F, Piana S, Andreoli A, Ricci R (1997) Low grade adenocarcinoma of endolymphatic sac mimicking jugular paraganglioma at clinical and neuroradiological examination. Clin Neuropathol 16:243-246
171. Rosenthal G, Israel Z, Umansky F (1998) Metastatic brain adenocarcinoma masquerading as recurrent haemangioblastoma. Acta Neurochir 140:1207-1208
172. Rouquette I, Delisle MB, Cervera P, Richard S, Uro E, Rumeau JL (1996) Adénocarcinome papillaire de bas grade du sac endolymphatique. A propos de trois observations avec étude immunocytochimique. Ann Pathol 16:271-275
173. Rubio A, Meyers SP, Powers JM, Nelson CN, de Papp EW (1994) Hemangioblastoma of the optic nerve. Hum Pathol 25:1249-1251
174. Sakashita N, Takeya M, Kishida T, Stackhouse TM, Zbar B, Takahashi K (1999) Expression of von Hippel-Lindau protein in normal and pathological human tissues. Histochem J 31: 133-144
175. Samii M, Klekamp J ( 1994) Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery 35:865-873
176. Scheithauer BW, Parameswaran A, Burdick B (1996) Intrasellar paraganglioma: report of a case in a sibship of von Hippel-Lindau disease. Neurosurgery 38:395-399
177. Schimke RN, Collins DL, Rothberg PG (1998) Functioning carotid paraganglioma in the von Hippel-Lindau syndrome. Am J Med Genet 80:533-534
178. Sgambatti MT, Stolle C, Choyke PL, Wakther MM, Zbar B, Linehan WM, Glenn GM (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 66:84-91.
179. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299-2301
180. Sims E, Doughty D, Macaulay E, Royle N, Wraith C, Darlison R, Plowman PN (1999) Stereotactically delivered cranial radiation therapy: a 10-year experience of linac-based radiosurgery in the UK. Clin Oncol (R Coll Radiol) 11:303-320
181. Sobottka SB, Frank S, Hampl M, Schackert HK, Schackert G (1998) Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease - a clinical and molecular study. Acta Neurochir (Wien) 140:281-285
182. Spetzger U, Bertalanffy H, Huffmann B, Mayfrank L, Reul J, Gilsbach JM (1996) Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 19:147-151
183. Standard SC, Ahuja A, Livingston K, Guterman LR, Hopkins LN (1994) Endovascular embolization and surgical excision for the treatment of cerebellar and brainstem hemangioblastomas. Surg Neurol 41:405-410
184. Statement of the American Society of Clinical Oncology (1996) Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736
185. Stebbins CE, Kaelin WG Jr, Pavletich NP (1999) Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455-461
186. Steinbach F, Novick AC, Zincke H, Miller D, Williams RD, Lund G, Skinner DG, Esrig D, Richie J, De Kernion JB, Marshal F, Marsh CL (1995) Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicentric study. J Urol 153: 1812-1816
187. Stendel R, Suess O, Prosenc N, Funk T, Brock M (1998) Neoplasm of endolymphatic sac origin: clinical, radiological, and pathological features. Acta Neurochir (Wien) 140:1083-1087
188. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423
189. Stratmann R, Krieg M, Haas R, Plate KH (1997) Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 56:1242-1252
190. Symon L, Murota T, Pell M, Bordi L (1993) Surgical management of haemangioblastoma of the posterior fossa. Acta Neurochir (Wien) 120:103-110
191. Tampieri D, Leblanc R, TerBrugge K (1993) Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery 33:502-505
192. Thomas CB, Kveton JF, Poe DS, Zamani A, Tarlov EC (1993) Aggressive papillary tumour of temporal bone in von Hippel-Lindau disease. Surg Pathol 5:63-71
193. Tibbs RE Jr, Bowles AP Jr, Raila FA, Fratkin JD, Hutchins JB (1997) Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery 40:848-855
194. Tibbs RE Jr, Harkey HL, Raila FA (1999) Hemangioblastoma of the filum terminale: case report. Neurosurgery 44:221-223
195. Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK (1997) Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am J Clin Pathol 107:459-466
196. Tyers M, Rottapel R (1999) VHL: a very hip ligase. Proc Natl Acad Sci USA 96:12230-12232
197. Van der Harst E, De Krijger RR, Dinjens WNM, Weeks LE, Bonjer HJ, Bruining HA (1998) Germline mutations in the VHL gene in patients presenting with phaechromocytomas. Int J Cancer 77:337-340
198. Vaquero J, Zurita M, Oya S, Coca S, Salas C (1999) Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor-associated cysts. J Neurooncol 41:3-7
199. Vazquez-Anon V, Botella C, Beltran A, Solera M, Piquer J (1997) Preoperative embolization of solid cervicomedullary junction hemangioblastomas: report of two cases. Neuroradiology 39:86-89
200. von Hippel E (1904) Ueber eine sehr seltene Erkrankung der Netzhaut. A von Graefes Arch Ophtalmol 59:83-106
201. Vortmeyer AO, Choo D, Pack SD, Oldfield E, Zhuang Z (1997) von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst 89:970-972
202. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, Zhuang Z (1997) von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540-543
203. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z (1997) Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 151:951-956
204. Vortmeyer AO, Chan CC, Chew EY, Matteson DM, Shen DF, Wellmann A, Weil R, Zhuang Z (1999) Morphologic and genetic analysis of retinal angioma associated with massive gliosis in a patient with von Hippel-Lindau disease. Graefes Arch Clin Exp Ophthalmol 237:513-517
205. Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM (1999) Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161: 1475-1479
206. Walther MM, Keiser HR, Choyke PL, Rayford W, Lyne JC, Linehan WM (1999) Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 161:395-398
207. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659-664
208. Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER (1998) An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 63:1025-1035
209. Webster AR, Maher ER, Bird AC, Gregor ZJ, Moore AT (1999) A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology 106:623-629
210. Webster AR, Maher ER, Moore AT (1999) Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 117:371-378
211. Werness BA, Guccion JG (1997) Tumor of the broad ligament in von Hippel-Lindau disease of probable mullerian origin. Int J Gynecol Pathol 16:282-285
212. Wittebol-Post D, Hes FJ, Lips CJ (1998) The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations. J Intern Med 243:555-5561
213. Wizigmann-Voos S, Breier G, Risau W, Plate KH (1995) Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358-1364
214. Wizigmann-Voos S, Plate KH (1996) Pathology, genetics, and cell biology of hemangioblastomas. Histol Histopathol 11:1049-1061
215. Woodward ER, Eng C, McMahon R, Voutilainen R, Affara NA, Ponder BA, Maher ER (1997) Genetic predisposition to phaechromocytoma: analysis of candidate genes GNDF and RET and VHL. Hum Mol Genet 6:1051-1056
216. Wysocka B, Welnicka-Jaskiewicz M, Matuszewska K, Sloniewski P, Jassem J, Izycka-Swieszewska E, Borowska-Lehman J, Limon J (1999). The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease. Folia Neuropathol 37:175-178
217. Yamamoto M, Ide M, Umebara Y, Hagiwara S, Jimbo M, Takakura K (1996) Gamma knife radiosurgery for brain tumors: postirradiation volume changes compared with preradiosurgical growth fractions. Neurol Med Chir (Tokyo) 36:358-363
218. Ye Y, Vasavada S, Kuzmin I, Stackhouse T, Zbar B, Williams BR (1998) Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent. Int J Cancer 78:62-69
219. Yu JS, Short MP, Schumacher J, Chapman PH, Harsh GR IV (1994) Intramedullary hemorrhage in spinal cord hemangioblastoma. Report of two cases. J Neurosurg 81:937-40
220. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CHM, Linehan WM, Lerman M (1996) Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348-357
221. Zbar B, Kaelin W, Maher E, Richard S (1999) Third International Meeting on von Hippel-Lindau disease. Cancer Res 59:2251-2253